Institutional Ownership
Biocryst Pharmaceuticals Inc
CUSIP 09058V103COMBCRXQ1 2026
Institutional Holders
290
13F filers
Shares Held
221.61M
Aggregate institutional
Institutional Value
$2.07B
Q1 2026
Net New Holders
+23
64 new · 41 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions64
Increased116
Decreased75
Sold out41
Institutional Holders
290 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 22.65M | $215.64M | +1.51M | Added |
| 2 | Ra Capital Management, L.P. | 15.83M | $150.67M | 0 | Held |
| 3 | Deerfield Management Company, L.P. | 15.04M | $143.16M | +697.0K | Added |
| 4 | State Street Corp | 12.21M | $116.22M | +1.14M | Added |
| 5 | Tcg Crossover Management, LLC | 11.02M | $104.92M | +11.02M | New |
| 6 | Janus Henderson Group PLC | 8.91M | $84.85M | +1.50M | Added |
| 7 | Perceptive Advisors LLC | 7.43M | $70.77M | +4.27M | Added |
| 8 | Vestal Point Capital, LP | 7.03M | $66.88M | +4.78M | Added |
| 9 | Two Sigma Investments, LP | 6.39M | $60.86M | +1.88M | Added |
| 10 | Geode Capital Management, LLC | 5.78M | $55.06M | +729.0K | Added |
280 more institutional holders on Premium
See every fund holding Biocryst Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders